Fareston Tablets

Toremifene (as citrate)
60mg
ORION CORPORATION (SCHERING-PLOUGH)
Pack size 100's (10's Blister x 10)
Dispensing mode POM
Source FINLAND
AgentCITY MEDICAL STORE
Retail Price 718.50 AED

Available as:

Indications

Fareston Tablets is used for: For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumors. Toremifene is currently under investigation as a preventative agent for prostate cancer in men with high-grade prostatic intraepithelial neoplasia and no evidence of prostate cancer.

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Toremifene (as citrate) :

Mechanism of Action

Toremifene is a nonsteroidal triphenylethylene derivative. Toremifene binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activities, depending upon the duration of treatment, animal species, gender, target organ, or endpoint selected. The antitumor effect of toremifene in breast cancer is believed to be mainly due to its antiestrogenic effects, in other words, its ability to compete with estrogen for binding sites in the cancer, blocking the growth-stimulating effects of estrogen in the tumor. Toremifene may also inhibit tumor growth through other mechanisms, such as induction of apoptosis, regulation of oncogene expression, and growth factors.

Note

Fareston 60mg Tablets manufactured by ORION CORPORATION (SCHERING-PLOUGH). Its generic name is Toremifene (as citrate). Fareston is availble in United Arab Emirates. Farmaco UAE drug index information on Fareston Tablets is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Toremifene (as citrate) :